Skip to main content
Medline10-Q: Regulatory investigation

FDA Issues Three Warning Letters Regarding Quality Management and cGMP Compliance at Manufacturing Facilities

Source: Autobound Signal API · 72 signals tracked for Medline · updated

Get Medline's live signals in Claude or ChatGPT, or by API

AskWhat changed at Medline this week? Use Autobound signals for medline.com.

What happened

Medline received three unresolved FDA warning letters regarding Quality Management System and cGMP regulations for facilities in Northfield, Glens Falls, and Waukegan, and has committed to remediation and Quality organization investments in H2 2026.

Source

SEC EDGARAug 5, 2026

Quarterly report (Form 10-Q)

Medline 10-Q for Quarter ended Jun 27, 2026

Filing excerpt

As of June 27, 2026, we have received three warning letters from the FDA, which have not been resolved. These warning letters relate to compliance with the Quality Management System Regulation and the current Good Manufacturing Practice (cGMP) regulations and were sent following inspections of Medline’s Northfield, Illinois facility and our manufacturing facilities in Glens Falls, New York and Waukegan, Illinois.

sec.gov/Archives/edgar/data/2046386/000204638626000051/mdln-20260627.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Regulatory investigation

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Jun 27, 2026
Fiscal year end
06/27
Filed
Aug 5, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
2046386
Accession number
0002046386-26-000051
Timeframe
Current quarter
Quarter
Q2
Filing year
2026
Period end date
Jun 27, 2026
Why it matters
Compliance tools urgently needed
Signal category
Risk

Topics and mentions

Regions named

  • Northfield, Illinois
  • Glens Falls, New York
  • Waukegan, Illinois

Extraction

Confidence
High
Relevance
85%
Sentiment
Negative
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
regulatoryInvestigation

Use this data

Get every 10-Q signal for Medline and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medline this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/f5d7181e-35ba-4541-82f6-8697f019ab88 returns this record as JSON. POST /v1/companies/enrich returns every signal for medline.com.

{
  "signal_id": "f5d7181e-35ba-4541-82f6-8697f019ab88",
  "signal_type": "sec-10q",
  "signal_subtype": "regulatoryInvestigation",
  "detected_at": "2026-11-09T06:32:59.308+00:00",
  "company": {
    "name": "Medline",
    "domain": "medline.com"
  },
  "data": {
    "detail": "Medline received three unresolved FDA warning letters regarding Quality Management System and cGMP regulations for facilities in Northfield, Glens Falls, and Waukegan, and has committed to remediation and Quality organization investments in H2 2026. This compliance remediation may create opportunities for quality management, regulatory consulting, and compliance software providers.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "quarter": "Q2",
    "summary": "FDA Issues Three Warning Letters Regarding Quality Management and cGMP Compliance at Manufacturing Facilities",
    "excerpts": "As of June 27, 2026, we have received three warning letters from the FDA, which have not been resolved. These warning letters relate to compliance with the Quality Management System Regulation and the current Good Manufacturing Practice (cGMP) regulations and were sent following inspections of Medline’s Northfield, Illinois facility and our manufacturing facilities in Glens Falls, New York and Waukegan, Illinois.",
    "relevance": 0.85,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2046386/000204638626000051/mdln-20260627.htm",
    "filing_date": "2026-08-05",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "06/27",
    "period_end_date": "2026-06-27",
    "sales_relevance": "Compliance tools urgently needed",
    "signal_category": "risk",
    "regions_mentioned": [
      "Northfield, Illinois",
      "Glens Falls, New York",
      "Waukegan, Illinois"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.